Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 16Lymphoid 7Myeloid 5Sarcoma 2Plasma cell 1

Conditions

Dendritic Cell Sarcoma, Interdigitating 17Lymphoma 13Leukemia, Myeloid, Acute 12Burkitt Lymphoma 12Lymphoma, Non-Hodgkin 11Lymphoma, Large B-Cell, Diffuse 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Leukemia 9Sarcoma, Myeloid 7Lymphoma, Large-Cell, Immunoblastic 7Lymphoma, Mantle-Cell 6Lymphoma, Follicular 6Blast Crisis 6Myelodysplastic Syndromes 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Myeloid, Accelerated Phase 5Leukemia, Lymphocytic, Chronic, B-Cell 5Recurrence 4Hodgkin Disease 4Congenital Abnormalities 4Neoplasms, Plasma Cell 3Myeloproliferative Disorders 3Multiple Myeloma 3Leukemia, Myelomonocytic, Juvenile 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Anemia, Refractory, with Excess of Blasts 3Anemia, Refractory 3Waldenstrom Macroglobulinemia 2

Interventions

Cyclophosphamide 4fludarabine phosphate 3fludarabine 2Whole-Body Irradiation 2Tacrolimus 2Mycophenolic Acid 2Cytarabine 2Azacitidine 2venetoclax 1thymoglobulin 1tazemetostat 1romidepsin 1quizartinib 1plerixafor 1glucarpidase 1cc-486 1capmatinib 1aldesleukin 1Zoledronic Acid 1Vincristine 1Transplantation 1Thiotepa 1Spironolactone 1Rituximab 1Rifampin 1Pravastatin 1Polymerase Chain Reaction 1Palliative Care 1Methotrexate 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hematologic Neoplasms × Cytarabine × Sarcoma × Clear all
NCT05735184 2026-03-13

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Kura Oncology, Inc.

Phase 1 Recruiting
420 enrolled
Other hematologic neoplasmSarcoma

Leukemia, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Sarcoma, Myeloid

NCT01621477 2017-02-20

T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

St. Jude Children's Research Hospital

Phase 2 Terminated
34 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Sarcoma, Myeloid, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡